Imugene Limited (IMU.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

0.0480

0.0000

(0.00%)

At close: 05:10PM AEDT

Loading interactive chart…

Simply Wall St.
Those who invested in Imugene (ASX:IMU) five years ago are up 144%
It might be of some concern to shareholders to see the Imugene Limited ( ASX:IMU ) share price down 19% in the last...
GlobeNewswire
Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma)
10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort A: 6 patients were treated with azer-cel and lymphodepletion (chemotherapy)1Cohort B: 4 patients were treated with azer-cel, lymphodepletion (chemotherapy)1, and interleukin 2 (IL-2) 3 complete responses - The first 2 patients treated in Cohort B achieved a complete response (CR) and 1 patient treated in Cohort A achieved a CRDurability of CRs in Cohort B; >120 days and >90 days
Simply Wall St.
Breakeven On The Horizon For Imugene Limited (ASX:IMU)
Imugene Limited ( ASX:IMU ) is possibly approaching a major achievement in its business, so we would like to shine some...